iLet spinoff is an artificial pancreas of a new generation for diabetics, which was created by Beta Bionics company. The main goal of the company is to facilitate the lives of people who live with diabetes or are associated with glycemic dysregulation. The team of the company consists of bioengineers from Boston University. Adaptive management of the artificial pancreas was developed by such scientists as Ed Damiano and Firas El-Hatib. Then it was laid on the basis of the iLet device.